. Author manuscript; available in PMC: 2021 Mar 10.

Published in final edited form as: Arch Dermatol Res. 2016 Oct 5;308(10):711–721. doi: 10.1007/s00403-016-1693-0

Table 1.

Impact of topically administered aceton/water solution of BMX-001 and BMX-010 on scratching behavior and ear swelling in the challenge phase of allergic contact dermatitis

Drug	Dose (mg/ml)	Ear swelling (μm, mean ± SD, n = 7)	Scratching bouts (60 min, mean ± SD, n = 7)
Vehicle	0	363 ± 46	108 ± 28
BMX-001	0.04	374 ± 48	ND
	0.1	388 ± 28	ND
	0.4	385 ± 56	136 ± 29
BMX-010	0.04	327 ± 59	ND
	0.1	356 ± 29	ND
	0.4	327 ± 43	130 ± 62
Triamcinolone	0.1	58 ± 35^**	ND

Results are expressed as mean ± 1 SD (n = 7 per group)

^**

P < 0.01 (Dunnett’s multiple comparison test) vs. vehicle-only control group ND not determined